SelectQuote, Inc. announced on January 15, 2026 that its SelectRx pharmacy division will enter into a new multiyear agreement with a long‑time pharmacy benefit manager partner, effective January 1, 2026. The deal covers all 100,000+ Medicare beneficiaries served by SelectRx across the United States and is backed by the company’s three pharmacy facilities in Pennsylvania, Indiana and Kansas. By locking in predictable reimbursement rates, the partnership is designed to provide greater financial stability for a rapidly expanding healthcare services platform that has already driven a 42% year‑over‑year increase in revenue for the Healthcare Services segment during the first quarter of fiscal 2026.
During the first quarter of fiscal 2026, SelectQuote reported consolidated revenue of $328.8 million, up 4% from the $318.99 million consensus estimate. The Healthcare Services segment generated $221.4 million, a 42% jump from $155.9 million in Q1 FY2025, reflecting strong demand for its patient‑centered pharmacy model. Net loss widened to $30.5 million, an improvement from the $44.5 million loss in the prior year, as the company continued to invest heavily in scaling its pharmacy network while managing operating costs.
The agreement was announced in the context of a recent capital structure reset that saw SelectQuote secure a $415 million credit facility on January 12, 2026. The facility consists of a $325 million term loan from Pathlight Capital and a $90 million revolving line from UMB Bank, extending debt maturities to January 2031 and providing liquidity to support ongoing expansion and margin improvement initiatives.
CEO Tim Danker emphasized that the new PBM contract “provides increased visibility to reimbursement rates, allowing us to continue to invest and grow our differentiated SelectRx pharmacy.” He added that the partnership “recognizes the clinical value we deliver to our SelectRx patients every day, helping them to achieve increased active medication adherence and improved health and wellness.” Danker also noted that the agreement, coupled with the capital structure refinancing, “allows our management team to devote even more focus to operating the business and executing our plan to drive meaningful cash flow for shareholders.”
The multiyear PBM agreement and the refinancing together position SelectQuote to accelerate its integrated healthcare model, which blends pharmacy services with its insurance distribution network. By securing stable reimbursement terms, the company can continue to invest in its high‑touch pharmacy model, improve medication adherence, and reduce hospital days—key drivers of long‑term member retention and lifetime value. The partnership also supports the company’s broader strategy of scaling the SelectRx platform, which is expected to contribute significantly to future revenue growth and margin expansion as the business scales and achieves greater operational leverage.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.